| Popis: |
Loredana Stavar-Matei,1,2 Oana-Mariana Mihailov,1 Alexandra-Mihaela Crestez,1,2 Anamaria Madalina Alexandru,1 Cristina-Mihaela Popescu,1,2 Aurel Nechita1,2 1Dunarea de Jos” University of Galati, Faculty of Medicine and Pharmacy, Galati,Romania; 2Sf. Ioan“ Children’s Clinical Emergency Hospital, Galati, RomaniaCorrespondence: Loredana Stavar-Matei, Email mateiloredana23@yahoo.comBackground: Bacterial pneumonia caused by Streptococcus pneumoniae continues to be one of the most common medical conditions in the pediatric population under 5 years of age, sometimes requiring prolonged hospitalizations and high costs. The time period (3 to 7 days) from the collection of biological samples (ie nasal exudate, pharyngeal exudate, sputum, blood culture and various secretions) to the arrival of the results has been a much discussed issue. Thus, the use of a rapid diagnostic test for Streptococcus pneumoniae urinary antigen, which is easy to use, may lead after the result is known to a targeted therapeutic management and thus to a favorable prognosis of the disease for the patient.Methods: This case report presents the case of a 4 years and 5 months old patient diagnosed with invasive pneumococcal-associated pneumococcal infection in the context of SARS-COV2 infection.Results: The clinical course was slowly favorable with complications that required a long hospitalization.Conclusion: In conclusion, some rapid diagnostic techniques, clinician judgment and some prevention methods, such as vaccination, can improve a patient’s quality of life. One prospect for the future would be the development of new vaccines covering other aggressive Streptococcus pneumoniae serotypes.Keywords: co-infections, pneumococcal urinary antigen test, therapeutic management, vaccination |
